Evidence map›Paper›PMID 31508243›Full record

ArticleNPJ genomic medicine2019

Predictive value of genomic screening: cross-sectional study of cystic fibrosis in 50,788 electronic health records.

J P Sugunaraj, H M Brosius, M F Murray, K Manickam, J A Stamm, D J Carey, U L Mirshahi

Abstract read
In one paragraph

Article in NPJ genomic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

J P SugunarajDepartment of Pulmonary and Critical Care Medicine, Geisinger, Danville, PA USA.ORCID 0000-0001-9156-663X
H M BrosiusDepartment of Pulmonary and Critical Care Medicine, Geisinger, Danville, PA USA.
M F Murray2Department of Genetics, Yale School of Medicine, New Haven, CT USA.
K Manickam3Division Genetic & Genomic Medicine, Nationwide Children's Hospital, Columbus, OH USA.
J A Stamm *Department of Pulmonary and Critical Care Medicine, Geisinger, Danville, PA USA.
D J Carey *Department of Molecular and Functional Genomics, Geisinger, Danville, PA USA.
U L Mirshahi *Department of Molecular and Functional Genomics, Geisinger, Danville, PA USA.ORCID 0000-0003-4972-5451

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Doubts have been raised about the value of DNA-based screening for low-prevalence monogenic conditions following reports of testing this approach using available electronic health record (EHR) as the sole phenotyping source. We hypothesized that a better model for EHR-focused examination of DNA-based screening is Cystic Fibrosis (CF) since the diagnosis is proactively sought within the healthcare system. We reviewed

Indexed as

Genetic techniquesPersonalized medicine

Identifiers

PMID31508243
PMCPMC6726623

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.